Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry C Kitchener

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
The Cochrane Database of Systematic Reviews|December 18, 2015
Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancerTheresa A Lawrie, Brett A Winter-Roach, Pauline Heus, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 30, 2010
Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysisEmma J Crosbie, Marcel Zwahlen, Henry C Kitchener, et al.
The Cochrane Database of Systematic Reviews|June 17, 2011
Adjuvant progestagens for endometrial cancerPierre Pl Martin-Hirsch, Andrew Bryant, Sarah L Keep, et al.
Journal of Clinical Microbiology|September 5, 2015
The PapilloCheck Assay for Detection of High-Grade Cervical Intraepithelial NeoplasiaEmma J Crosbie, Andrew Bailey, Alex Sargent, et al.
BMC Cancer|November 5, 2014
Tumour suppressor gene methylation and cervical cell folate concentration are determinants of high-risk human papillomavirus persistence: a nested case control studyJanet E Flatley, Alexandra Sargent, Henry C Kitchener, et al.
Health Technology Assessment (Winchester, England)|April 26, 2014
The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening roundsHenry C Kitchener, Karen Canfell, Clare Gilham, et al.
Frontiers in Oncology|March 7, 2015
The cervix cancer research network: increasing access to cancer clinical trials in low- and middle-income countriesGita Suneja, Monica Bacon, William Small, et al.
European Journal of Cancer (Oxford, England : 1990)|November 22, 2011
Body mass index does not influence post-treatment survival in early stage endometrial cancer: results from the MRC ASTEC trialEmma J Crosbie, Chris Roberts, Wendi Qian, et al.
Genome Medicine|March 29, 2012
Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformationAndrew E Teschendorff, Allison Jones, Heidi Fiegl, et al.
International Journal of Cancer|August 20, 2016
Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countriesKate T Simms, Megan A Smith, Jie-Bin Lew, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
The Cochrane Database of Systematic Reviews|December 18, 2015
Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancerTheresa A Lawrie, Brett A Winter-Roach, Pauline Heus, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 30, 2010
Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysisEmma J Crosbie, Marcel Zwahlen, Henry C Kitchener, et al.
The Cochrane Database of Systematic Reviews|June 17, 2011
Adjuvant progestagens for endometrial cancerPierre Pl Martin-Hirsch, Andrew Bryant, Sarah L Keep, et al.
Journal of Clinical Microbiology|September 5, 2015
The PapilloCheck Assay for Detection of High-Grade Cervical Intraepithelial NeoplasiaEmma J Crosbie, Andrew Bailey, Alex Sargent, et al.
BMC Cancer|November 5, 2014
Tumour suppressor gene methylation and cervical cell folate concentration are determinants of high-risk human papillomavirus persistence: a nested case control studyJanet E Flatley, Alexandra Sargent, Henry C Kitchener, et al.
Health Technology Assessment (Winchester, England)|April 26, 2014
The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening roundsHenry C Kitchener, Karen Canfell, Clare Gilham, et al.
Frontiers in Oncology|March 7, 2015
The cervix cancer research network: increasing access to cancer clinical trials in low- and middle-income countriesGita Suneja, Monica Bacon, William Small, et al.
European Journal of Cancer (Oxford, England : 1990)|November 22, 2011
Body mass index does not influence post-treatment survival in early stage endometrial cancer: results from the MRC ASTEC trialEmma J Crosbie, Chris Roberts, Wendi Qian, et al.
Genome Medicine|March 29, 2012
Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformationAndrew E Teschendorff, Allison Jones, Heidi Fiegl, et al.
International Journal of Cancer|August 20, 2016
Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countriesKate T Simms, Megan A Smith, Jie-Bin Lew, et al.
Pageof 9